ARCHIVES

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 35 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Study Links Obesity To Higher Risk of Ovarian Cancer

January 30, 2009

Moyniham Bill Will Direct HHS to Exempt Centers Recognized By NCI From Prospective Payment System

August 15, 1986

NCI To File Record No. Of INDS In ’92, Expand Phase 1 Trials

March 6, 1992

New Carfilzomib Combination Produces Near Remissions

June 29, 2012

DeVita Resigns As No. 2 At Sloan-Kettering To “Pursue Clinical Research,” Hospital Says

May 31, 1991

HHS Proposes Stronger Health Warnings On Cigarette Packages, Ads

November 12, 2010